Safety and Efficacy Evaluation of Serplulimab Plus Chemo in SCLC Transformed From EGFR-mutated NSCLC After Treatment
Condition: Small-cell Lung Cancer Intervention: Drug: Serplulimab Sponsors: Guangdong Association of Clinical Trials; Guangdong Provincial People's Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Hospitals | Non-Small Cell Lung Cancer | Research | Small Cell Lung Cancer